Characterizing the function of pUL33 of HSV-1 in viral DNA cleavage and packaging

表征 HSV-1 的 pUL33 在病毒 DNA 切割和包装中的功能

• 批准号: 8883366
• 负责人: KUI YANG
• 金额: $ 18.5万
• 依托单位: LOUISIANA STATE UNIV A&M COL BATON ROUGE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-07-01 至 2018-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8883366
• 关键词: Address; Antiviral Agents; Baculoviruses; Binding; Biochemical; Biological Assay; Blindness; Capsid; Cells; DNA; DNA Binding; DNA Binding Domain; DNA Packaging; DNA-Binding Proteins; DNA-dependent ATPase-endonuclease; DNase-I Footprinting; Data; Development; Drug Targeting; Drug resistance; Elements; Encephalitis; Enzymes; HIV; Health; Herpesviridae; Herpesvirus 1; Herpetic Stomatitis; Human; Human Herpesvirus 2; Individual; Infection; Keratitis; Laboratories; Lead; Life; Life Cycle Stages; Maps; Measures; Mediating; Methods; Mutation; Play; Population; Process; Proteins; Reaction; Recombinants; Research; Role; Sexually Transmitted Diseases; Signal Transduction; Simplexvirus; Site; Surface Plasmon Resonance; Testing; Ulcer; United States; Viral Genes; Viral Genome; Viral Proteins; Virus; Virus Diseases; Virus Replication; genital herpes; in vivo; novel; pathogen; terminase; treatment strategy; viral DNA

DESCRIPTION (provided by applicant): Herpes simplex virus (HSV) is a significant human pathogen infecting 65%-90% of the population worldwide and primarily causing oral (HSV-1) or genital (HSV-2) mucocutaneous ulcers. More serious infections can result in life-threatening encephalitis, and keratitis from HSV infection is the leading cause of blindness in the United States. HSV-2 is one of the most prevalent sexually transmitted diseases worldwide; it is also a significant co-factor for HIV spread. Several antivirals are approved for the treatment of HSV infections, but their efficacy is limited to the period before latency is established and can be compromised by the emergence of drug resistance. It is, therefore, important to investigate new drug targets and treatment strategies. The cleavage and packaging of the viral DNA into preassembled capsids is a critical step in the life cycle of herpes virus replication; understandin this process has an important practical implication because it provides a rich target for developing novel anti-herpes virus strategies. This DNA cleavage and packaging reaction is mediated by terminase, a virally-encoded enzyme composed of pUL15, pUL28 and pUL33 in HSV. All terminase subunits are essential for DNA packaging, but the roles of individual subunits are unclear. Until now, no viral protein has been identified that binds to the sites known to be required for initiation of the DNA-cleavage/packaging reaction. We have recently made a significant advance in purifying and characterizing pUL33. In preliminary data, we show that pUL33 binds to the pac2 sequence and speculate that this serves to initiate the DNA-cleavage/packaging process. Using methods developed in our laboratory, we propose to (i) characterize the DNA-binding activities of pUL33, (ii) map the functional domains of pUL33, and (iii) test whether the DNA-binding activity plays an important role in cleavage of DNA in infected cells. These studies will directly address an important issue in the field: how the terminase recognizes packaging signals in the viral genome to initiate the DNA-cleavage / packaging processes. In addition, studies on the mechanism of DNA-cleavage/ packaging may lead to development of novel anti-herpes virus strategies.

描述（由申请人提供）：单纯疱疹病毒（HSV）是一种重要的人类病原体，感染全球65%-90%的人口，主要引起口腔（HSV-1）或生殖器（HSV-2）粘膜皮肤溃疡。更严重的感染会导致危及生命的脑炎，在美国，由单纯疱疹病毒感染引起的角膜炎是导致失明的主要原因。2型单纯疱疹病毒是世界上最普遍的性传播疾病之一；它也是艾滋病毒传播的重要辅助因素。几种抗病毒药物已被批准用于治疗单纯疱疹病毒感染，但它们的疗效仅限于潜伏期确定之前的一段时间，并可能因耐药性的出现而受到损害。因此，研究新的药物靶点和治疗策略非常重要。病毒DNA的切割和包装成预组装衣壳是疱疹病毒复制生命周期的关键步骤；了解这一过程具有重要的实际意义，因为它为开发新的抗疱疹病毒策略提供了丰富的靶点。这种DNA切割和包装反应是由末端酶介导的，末端酶是一种在HSV中由pUL15、pUL28和pUL33组成的病毒编码酶。所有的末端酶亚基都是DNA包装所必需的，但单个亚基的作用尚不清楚。到目前为止，还没有发现能与已知位点结合的病毒蛋白